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Temperature is an important attribute of life. Radiofrequency (RF) pulses used 
for magnetic resonance (MR) spin excitation can be deliberately used to apply a 
thermal stimulus. Thermal MR integrates this thermal modulation with the imaging 
capabilities of a MR device providing a tool to study the role of temperature in 
biological systems, diagnostic contrasts and thermal therapies (e.g. temperature 
controlled release of a load from thermoresponsive carriers). 
Thermal MR requires an RF chain that includes dedicated transmit/receive 
(Tx/Rx) switches that support high peak powers for MR imaging and high average 
powers for RF heating. Conventional Tx/Rx switches have electronic components 
in the transmission path limiting the average power handling. In this work, a high 
power handling Tx/Rx switch design is developed, implemented, and evaluated. 
This technology was applied in a pilot study in humans and in a feasibility study 
demonstrating the proof-of-principle of Thermal MR for temperature controlled 
release of a protein from thermoresponsive nanogels.  
 
Methods 
In the Tx/Rx switch design, λ/4 stubs were used to route the transmitted RF signal 
directly to the RF coil/antenna without passing through any electronic 
components (e.g. PIN diodes). Bench measurements, MR imaging, MR 
thermometry, and RF heating experiments were performed at f=297MHz (B0=7T) 
to examine the characteristics and applicability of the switch.  
Bovine serum albumin (BSA) was loaded to thermoresponsive nanogels 
(transition temperature = 38°C). As a reference, the release rate was firstly 
accessed using water bath heating at temperatures: 20°C, 37°C and 43°C. BSA 
release from the nanogel was subsequently studied using RF heating of Thermal 
MR at the same temperatures. In this Thermal MR setup one bow tie dipole 





The proposed design for the Tx/Rx switch provided 35.7dB/41.5dB (Tx/Rx) of 
isolation and 0.41dB/0.27dB (Tx/Rx) of insertion loss. The switch supported high 
peak (3.9kW) and high average (120W) RF powers for MRI and RF heating. High-
resolution MRI of the wrist yielded image quality competitive with that obtained 
with a conventional Tx/Rx switch. RF heating in phantom monitored by MR 
thermometry demonstrated the switch applicability for thermal modulation.  
The release of BSA from the thermoresponsive nanogels after 6 hours was 12.5% 
(20°C), 19.5% (37°C) and 32.8% (43°C) in water bath and 12.9% (20°C), 19.6 
(37°C) and 29.3% (43°C) with Thermal MR. 
 
Conclusion 
The high-power Tx/Rx switch enables thermal MR applications at 7.0 Tesla. The 
reference release profile of the therapeutic load model from the nanocarrier 
obtained with a water bath setup used for temperature intervention is in 
accordance with the release kinetics deduced from the thermal MR setup.  This 
finding supports the feasibility of thermal MR for temperature controlled release 







Temperatur ist eine physikalische Größe und wichtige Eigenschaft biologischer 
Systeme. Hochfrequenzimpulse zur Spinanregung in der 
Magnetresonanztomographie (MRT) können gezielt zur Erzeugung eines 
thermischen Stimulus eingesetzt werden (Thermale MR, tMR). Die tMR verbindet 
eine solche thermische Modulation mit der MRT und stellt somit ein Werkzeug 
zur Untersuchung der Rolle von Temperatur in biologischen Systemen, zur 
Darstellung diagnostischer Kontraste, sowie zur Therapie (z.B. durch kontrollierte 
Freisetzung einer Ladung von thermoreaktiven Trägern) dar. Allerdings benötigt 
die tMR eine HF-Kette mit speziellen Sende/Empfangsschaltern (Tx/Rx), welche 
sowohl hohe Spitzenleistungen für die MRT, als auch hohe Durschnittsleistungen 
für die thermische Stimulation zulassen. Letztere Anforderung wird durch 
konventionelle Tx/Rx Schalter nicht erfüllt. Zur Lösung wurde in dieser Arbeit ein 
neues Tx/Rx Schalterdesign entwickelt, implementiert und evaluiert. Die 
entwickelte HF-Technologie wurde in einer Human-Pilotstudie zur Anwendung 
geführt. Zusätzlich wurde sie in einer Machbarkeitsstudie an Messphantomen 
eingesetzt, um die kontrollierte Freisetzung eines Proteins aus einem 
thermoreaktiven Nanogel mittels tMR zu demonstrieren. 
 
Methoden 
Im entwickelten Tx/Rx Schalter wurden λ/4 Stichleitungen integriert, um das HF-
Signal direkt zur HF-Antenne zu leiten, ohne durch elektronische Komponenten 
(z.B. PIN Dioden) zu gelangen. Alle Experimente (MRT, MR-Thermometrie und 
HF Erwärmung) wurden bei einer Frequenz von 297MHz (B0=7.0T) durchgeführt, 
um die Eigenschaften des Schalters zu untersuchen. 
Ein thermoreaktives Nanogel (Übergangstemperatur=38°C) wurde mit 
Rinderserumalbumin (BSA) beladen. Als Referenz diente die Freisetzungskinetik 
im Wasserbad bei Temperaturen von 20°C, 37°C und 43°C. Die BSA Freisetzung 
durch HF Erwärmung mit tMR wurde bei den selben Temperaturen gemessen. 
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Der entworfene Tx/Rx Schalter führte zu eine Isolierung von 35.7dB/41.5dB und 
einer Dämpfung von 0.41dB/0.27dB während des Sendens/Empfangens. Der 
Schalter ermöglichte hohe Spitzen- (3.9kW) und Durchschnittsleistungen (120W) 
für MRT und tMR. Hochaufgelöste MRT-Bilder des Handgelenks zeigten eine 
Bildqualität vergleichbar mit Aufnahmen eines konventionellen Tx/Rx Schalters. 
Die durch tMR induzierte Erwärmung des Phantoms demonstrierte die Eignung 
des Schalters für thermische Modulation. Die BSA-Freisetzung betrug nach 6 
Stunden 12,5% (20°C), 19,5% (37°C) und 32,8% (43°C) im Wasserbad und 
12,9% (20°C), 19,6% (37°C) und 29,3% (43°C) mit tMR. 
 
Fazit 
Der entwickelte Hochleistungs-Tx/Rx-Schalter ermöglicht tMR bei 7.0T. Das 
Freisetzungsprofil der im Wasserbad gemessen Referenzdaten stimmt mit der 
durch tMR erzeugten Freisetzungskinetik überein. Diese Ergebnisse 
demonstrieren die Realisierbarkeit einer kontrollierten Freisetzung der Ladung 






1. Introduction  
 
Part of this thesis is based on the work published on Ji et al. 2018 [1]; therefore, 
it contains direct passages from this publication.   
 
Temperature is a physical parameter with diverse biological implications [2] and 
strong clinical interest. Therapies with thermal intervention include thermal 
ablation (<60 °C) for neurosurgery [3], hyperthermia (41-45 °C) as adjuvant 
treatment to chemo- and radiotherapies [4], and temperature controlled drug 
release [5]. 
All the thermal interventions need an anatomical reference to localize the target 
site to apply the heat, temperature monitoring to assure the correct amount of 
heat is delivered (too high temperatures can burn the tissue, while too low 
temperatures might not achieve desired therapeutic effect), and a source to 
deliver the heat. Here the magnetic resonance system is a valuable tool, as it 
provides high tissue contrast anatomical images, non-invasive temperature 
monitoring by means of magnetic resonance thermometry (MRTh), and the 
radiofrequency (RF) pulses tailored for spin excitation for imaging can also be 
used for the application of a thermal stimulus [6]. The addition of a thermal 
modulation to magnetic resonance imaging is denoted as thermal magnetic 
resonance – thermal MR. 
 
1.1. Thermal magnetic resonance 
 
The radiofrequency pulses used in magnetic resonance imaging are 
electromagnetic waves with an electric and a magnetic field components. While 
the magnetic field is used for imaging, the electric field power can be absorbed 
by the tissue and cause temperature rise. The tissue heating is considered an 
undesired side effect of MRI and regulatory organizations such as the 
International Electrotechnical Commission (IEC) restrict the maximum input 
power of  RF to assure patient safety [7]. 
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At ultrahigh field magnetic resonance (UHF-MR, B0 ≥ 7.0 T, f ≥ 300 MHz), the 
shortening of the radiofrequency (RF) wavelength in tissue gives rise to high 
focusing of RF fields due to constructive interference [6,8]. Contrary to the notion 
that this phenomenon is considered an adverse outcome, the potential to focus 
radiofrequency (RF) energy onto a small target region can be translated into 
localized power deposition, a means for targeted RF induced temperature 
modulation. This approach, denoted as Thermal MR (Figure 1),  uses the pulsed 
power amplifier of the MR system together with dedicated RF antenna arrays to 
generate RF induced focal thermal modulation in combination with higher signal-
to-noise ratio imaging capabilities of UHF-MR. 
 
 
Figure 1 – Thermal magnetic resonance. a) Photograph of a bow tie dipole RF antenna 
building block. b) Thermal MR applicator with eight bow tie antenna RF antennae. c) MR 
images of a brain acquired with Thermal MR applicator. d) Temperature simulation and 
MR thermometry showing the hotspot created by Thermal MR applicator in the middle of 
a phantom. Image adapted from [6]. 
 
Performing MRI and RF heating simultaneously requires high peak power (>1 
kW) and high average power (100 W per channel), support of the RF antennae 
as well as other RF hardware components. While RF antennae have already 
been developed for thermal MR, high peak and high average RF power 
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transmit/receive (Tx/Rx) switches – that alternate between high power (kW) 
transmission to low power (μW) reception of the RF signal – are still lacking.  
Magnetic resonance Tx/Rx switches deploy positive-intrinsic-negative (PIN) 
diodes as active switching units, as they offer very low resistance in forward 
biased state, high isolation in the reverse bias state, fast switching time and high 
peak power handling. In conventional Tx/Rx switch designs, PIN diodes are 
directly in the transmission pathway, limiting the average power handling (e.g. at 
high duty cycles). Thus, the overall applicable average power is limited severely 
in order to avoid excessive heat accumulation in these components. A Tx/Rx 
switch design that route transmitted RF signal directly to the RF antenna without 
electronic components on the transmission path would handle higher power RF 
pulses. 
 
1.2. Temperature controlled load release 
 
The delivery of therapeutics to its target site is a crucial requirement for a 
successful treatment. The lack of specificity in the current delivery of drug 
formulations can cause systemic side effects and/or have a low available 
therapeutic dose at the target [9–11]. To address these shortcomings, 
nanotechnology has played an important role in smart delivery of drugs, contrast 
agents, genes, proteins, etc. [12–15]. One of the novel delivery methods is based 
on stimulus-responsive smart carriers that deliver their load upon one or more 
stimuli [16–18]. Such stimuli can be internal, related to changes in the 
microenvironment of certain diseases (pH variations, hormone concentrations, 
redox gradient, etc.), or external such as heat, light or magnetic field [14,19]. The 
temperature stimulus is particularly interesting as it can be externally applied and 
thus be spatially and temporally controlled including reaching deep lying tissues 
[20–22].  
There are many formulations for thermoresponsive carriers: liposomes [15,23], 
polymers [5,20], nanogels [24] and many others. All of them present a sharp 
phase transition upon reaching a transition temperature and consequently, 
release their load (e.g. a drug or a contrast agent, Figure 2). In this way, the drug 
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is only released on the heated target site, avoiding systemic toxicity and 
increasing therapeutic dose.  
 
 
Figure 2 – Schematics of drug release from a thermoresponsive nanogel upon reaching 
its transition temperature. Courtesy of Dr. Lucila Navarro, Freie Universität Berlin. 
 
 
1.3. Goal of this doctoral work 
 
The goal of this doctoral work is firstly to develop a new design for a high power 
Tx/Rx switch that can perform MR imaging, comparable to conventional switches, 
and at same time, handle high power demands required for RF heating in a 7.0 
Tesla magnetic resonance system. With the developed high power Tx/Rx switch, 
the second goal of this work is to demonstrate the feasibility of using 





2. Materials and Methods 
 
2.1. Transmit and Receive Tx/Rx switch 
 
2.1.1. Circuit design 
The circuit of the proposed Tx/Rx switch is shown in Figure 3. It consisted of 3 
quarter wavelength (λ/4) stubs and two pin diodes (MA4P7441F-1091T, Macom, 
MA, USA): D1 and D2. An LC resonant circuit tuned to 297 MHz (7.0 Tesla) is 
placed between each pin diode and λ/4 stub to afford maximum isolation between 
transmission (Tx) and receive (Rx) paths. The LC resonant circuits were placed 
in double shielded compartments to increase isolation (Tx and Rx 
compartments). A copper plate with 2.5 x 4 mm2 and 2 mm of thickness was 
placed under each pin diodes for heat dissipation (Figure 4). The λ/4 stubs were 
assembled with semi-rigid coaxial cable (Sucoform 141 Cu 50 Ω, Huber+Suhner 
AG, Herisau, Switzerland) for 297 MHz.  
 
 
Figure 3 – Circuit diagram of the high power Tx/Rx switch. Image adapted from [1].  
 
During the transmission mode, the pin diodes are forward biased. The low 
impedance at points 1 and 4 (Figure 3) is transformed into high impedance at 
points 2 and 3 by the λ/4 stubs. In this way, all RF signal from Tx port is routed 
into the RF coil.  
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During the receive mode, the pin diodes are reverse biased. The high impedance 
at point 4 is transformed in low impedance at point 3 and again in high impedance 
at point 2 by the λ/4 stubs, directing the received signal from the antenna into the 
receive port.  
 
 
Figure 4 – Constructed high-power Tx/Rx switch. Image adapted from [1]. 
 
The isolation and insertion loss of the high-power Tx/Rx switch were accessed 
by measuring scattering parameters (S-parameters) using a vector network 
analyzer (ZVT 8, Rhode & Schwarz, Memmingen, Germany). 
The power handling of the switch was tested by applying an average power (Pavg) 
of 100 W. The power was generated by an MR RF power amplifier (8 kW peak 
power, 4 ms rectangular pulse, U = 332 V) with a duty cycle of 10%. As reference, 
a conventional Tx/Rx switch (Stark Contrasts, Erlangen, Germany) used for MR 
imaging at 7.0 T was also submitted to the same average power. The temperature 
of both switches while operating at 100 W was monitored with an infrared camera 
(Ti25, Fluke, WA, USA).  
 
2.1.2. MR imaging test  
To test the suitability of the high-power Tx/Rx switch for MR imaging, we 
performed MRI on a human wrist in a B0 = 7.0 T whole body MR system 
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(Magnetom, Siemens Healthcare, Erlangen, Germany) using one bow tie dipole 
antenna for transmission and reception of RF signal. A rapid acquisition with 
refocused echoes (RARE) technique was used; in plane resolution = (0.3 × 0.3) 
mm2, slice thickness = 3 mm, matrix size = (320 × 320) mm2, number of slices = 
11, TR = 3000 ms, TE = 59 ms, nominal flip angle = 150°, reference transmitter 
voltage = 250 V, total scan time = 149 s. As reference, a conventional Tx/Rx 
switch was used in the same setup for image quality comparison. 
 
2.1.3. RF induced heating and MR thermometry  
An experimental setup comprising a rectangular agarose phantom (90 × 180 × 
260 mm3) and a bow tie dipole antenna [4] (Figure 5a) was used to examine the 
suitability of the high-power Tx/Rx switch for RF heating in a B0 = 7.0 T MR 
system and also for temperature monitoring using MR thermometry (MRTh). The 
agarose phantom (σ = 1.12 S/m, εr = 84.4) had seven cylindrical sample holders; 
five were located in the RF heating range of a dipole antenna and two were 
located outside the heating range, Figure 5b. 1 mm tubes were inserted along 
the long axis of the phantom at depth of 5, 15, 25 and 35 mm (Figure 5c) for 
accommodating fiber optic probes that were used as temperature reference for 
MRTh.  
 
Figure 5 – a) RF heating setup. b) Agarose phantom with 7 cylindrical sample holders. 
c) Frontal view of the phantom with an indication of the location of the tubes for 




RF heating was accomplished using the MR RF power amplifier; 8 kW peak 
power, 4 ms rectangular pulse, U = 290 V and TR = 40 ms, duty cycle = 10%. 
This setup afforded a measured average power of 100 W at feeding point of the 
dipole antenna. The heating paradigm consisted of 3 × 5 min RF heating 
interleaved with 2D MRTh acquisition.  2D MRTh was conducted using a proton 
resonance frequency shift method and dual gradient-echo technique (in plane 
resolution = (1.5 × 1.5) mm2, slice thickness = 4 mm, matrix size = (192 × 192), 
number of slices = 3, TR = 61 ms, TE1 = 2.26 ms and TE2 = 11.44 ms, nominal 
flip angle = 30°, total scan time = 11 s). A fiber optic probe (Omniflex, Neoptix, 
Quebec, Canada) placed 15 mm below the RF antenna was used as temperature 
reference. 
For comparison, we used a conventional Tx/Rx switch but applied only Pavg = 25 
W (U = 154 V, 4 ms rectangular pulse, TR = 40 ms, 10% duty cycle) – maximum 
power established by manufacturer, and performed the same heating paradigm.  
 
 
2.2. Load release from thermoresponsive carriers  
 
2.2.1. Synthesis and characterization of thermoresponsive nanogels 
The themoresponsive nanogels were synthesized using nanoprecipitation 
methodology with acrylated dendritic polyglycerol (Ac-dPG) as macromolecular 
cross-linker and temperature-sensitive polymers poly(N-isopropylacrylamide) 
(PNIPAM) and poly(N-isopropyl methacrylamide) (PNIPMAM) as linear 
counterpart. The thermoresponsive nanogels were synthesized by my cooperator 
Dr. Lucila Navarro, Freie Universität Berlin. 
The acrylated dendritic polyglycerol (Ac-dPG, 7%) was synthesized with dendritic 
polyglycerol (dPG) obtained from Nanopartica GmbH, Berlin, Germany with a 
molecular weight (MW) of 10 kDa and a polydispersive index of 1,3. The dPG 
was pre-dried in vacuum at 80 °C for 24 h and (7% mol OH groups, 1 eq.) was 
dissolved in 20 mL of dry dimethylformamide (DMF). The solution was cooled 
down on ice and triethylene amine (2 eq.) was added to the flask followed by the 
dropwise addition of acryloyl chloride (1.3 eq.) under argon atmosphere. The 
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solution was stirred for 4 h and then quenched by adding a small amount of water. 
Ac-dPG was purified by dialysis using a regenerated cellulose membrane 
(molecular weight cut-off (MWCO) 1 kDa) in water for 2 days. The product was 
obtained with a yield of 85-90% and stored at 6-8 °C. The synthesis of Ac-dPG 
was characterized by 1H-NMR using a 400 MHz NMR spectrometer (Jeol, ECX 
400, Tokyo, Japan).  
Thermoresponsive nanogels (NGs) were synthesized according to previously 
reported methodologies [25] with minor modifications. In brief, a total amount of 
100 mg of the monomers; 30 mg of Ac-dPG, 42 mg of PNIPAM and 28 mg of 
PNIPMAM, and 1.8 mg of dodecyl sulfate sodium were dissolved in 4 mL of 
distilled water. The reaction was purged with argon for 30 minutes and then 
transferred to an oil bath at 70 °C. After 15 min, 1 mL of a solution of potassium 
persulfate (3.3 mg/mL) was added to initiate the polymerization. The reaction 
mixture was stirred for 4 h at 70 °C. The nanogels were purified for 3 days via 
dialysis (regenerated cellulose, MWCO 50 kDa) in water. The product was 
lyophilized and rendered a white cotton-like solid in a yield of 80-90%. 
The characterization of the structure was performed by 1H-NMR using a 400 MHz 
NMR spectrometer (Jeol, ECX 400, Tokyo, Japan). The size, the polydispersive 
index and the volume phase transition temperature (VPTT) of the nanogels were 
evaluated using dynamic light scattering technique. A Malvern Zetasizer Nano-
ZS 90 (Malvern Instrument, Malvern, Worcestershire, UK) equipped with a red 
He-Ne laser (λ=633 nm, 4.0 mW) was used for the measurement under a 
scattering angle of 173°. Prior testing, the samples were left to stabilize for 5 min 
under a certain temperature. The VPTT was determined by measuring the size 
of the nanogels in a range of 25-55 °C using a heating rate of 1 °C/min. The VPTT 
is defined as the temperature of the inflection point of the normalized size vs 
temperature curve.   
 
2.2.2. Protein encapsulation in the thermoresponsive nanogels 
Bovine serum albumin labeled with fluorescein (BSA-FITC) was used as a model 
therapeutic for release experiments. To encapsulate the BSA-FITC, the dry 
nanogel (5 mg) was swollen in 1 mL of a solution of BSA-FITC in phosphate buffer 
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saline (PBS) (0.5 mg/mL, pH 7.4) for at least 24 h at 4 °C. The solution was 
purified three times using Vivaspin 300 kDa centrifugal filter (5 mL, 10 min each 
time, speed = 4800 x g, Vivaspin 6, Sartorius AG, Göttingen, Germany). With this 
procedure, the nanogels were retained in the concentrate and the non-
encapsulated BSA-FITC (MW = 66 kDa) was washed out with the filtrate. The 
concentration of encapsulated BSA-FITC was determined by fluorescence 
(excitation wavelength (λex) = 490 nm and emission wavelength (λem) = 525 nm).  
 
2.2.3. Protein Release study in water bath 
An initial evaluation of the release profile of the BSA-FITC was evaluated using 
a water bath as a heat source. The above-mentioned nanogel loaded with BSA-
FITC was diluted with buffer (PBS, pH 7.4) to a final concentration of 1 mg/mL of 
nanogel. Three Vivaspin filters (Vivaspin 500, Sartorius AG, Göttingen, 
Germany), each with 400 uL of the diluted solution, were placed in the water bath 
at 20 °C (room temperature), 37 °C and 43 °C. The filters were wrapped with 
parafilm to avoid contact with water of the water bath. At certain time intervals, 
the samples were centrifuged (10 min, 4800 x g) and the filtrates were taken for 
analysis (fluorescence at λex/λem = 490/525 nm), while the same volume was 
replaced with fresh buffer. The filters were weighed before and after 
centrifugation to calculate the volume of buffer to be replaced. 
 
2.2.4. Phantom design for radiofrequency induced heating in an MR scanner 
A dedicated phantom was designed to carry out temperature controlled release 
experiments in a 7.0 T whole-body MR system (Siemens Healthineers, Erlangen, 
Germany), as depicted in Figure 6a. 
The phantom comprises a 180 × 280 × 90 mm3 rectangular box filled with agarose 
gel (20 g/L) dopped with NaCl (5 g/L) and CuSO4 (0.7 g/L), yielding a conductivity 
(σ) of 1.03 S/m and a relative permittivity (εr) of 71.9 at 297.2 MHz (working 
frequency of the MR scanner). Seven cylinder containers with inner diameter = 
22 mm and height = 30 mm were inserted into the phantom as sample holders 
(Figure 6b): five were placed in the hotspot area produced by bow-tie dipole 
antenna (for heated sample), and the other two were placed where the antenna 
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would not produce temperature rise (for control sample). Polytetrafluoroethylene 
(PTFE) tubes with inner diameter = 1 mm were inserted along the long axis of the 
phantom at depth of 5 mm, 15 mm, 25 mm and 35 mm (Figure 6c) to 
accommodate fiber optic probes that serve as temperature reference for MR 
thermometry (MRTh). The phantom could be placed in a water box connected to 
a water bath to modify the background temperature. 
Electromagnetic field simulation using the finite-difference time-domain method 
and temperature simulations solving Pennes bioheat equation (Sim4life, ZMT 
AG, Zurich, Switzerland) were performed to study the heat distribution induced 
by radiofrequency energy in the phantom. The simulation setup is depicted in 
Figure 6d; the phantom was placed inside a water box (250 × 360 × 120) mm3, 
with background temperature set as 37 °C, and a bow-tie dipole antenna was 
placed on top, centered on the heated sample. The basic mesh resolution of (5 × 
5 × 5) mm3 was locally refined to (0.5 × 0.5 × 0.5) mm3 in order to secure all 
electrical connections, resulting in a total mesh of 10 million cells. The 
electromagnetic field simulations were performed at 297.2 MHz, the working 
frequency of the MR scanner. 
 
 
Figure 6 – a) Agarose phantom with sample holders, five in the center of RF heating 
range and two outside of this range. b) Schematics of the phantom, top view. c) 
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Schematics of the phantom, frontal view with the positioning of the PTFE tubes for the 
insertion of fiber optic temperature sensors. The PTFE tubes were placed at each side 
of the sample holders (note, the holders are not all in the same plane) at a depth of 5, 
15 and 25 mm and at bottom of the holders at a depth of 35 mm). d) Setup for the 
electromagnetic field and temperature simulations. The phantom was placed inside a 
water box with background temperature of 37 °C, and a bow-tie dipole antenna was 
placed on top, centered in the heated sample. 
 
 
2.2.5. Experimental setup for radiofrequency induced heating in an MR scanner 
The radiofrequency (RF) heating induced release experiment was carried out in 
a whole body 7.0 T MR system using one bow-tie dipole antenna. The 
experimental setup (Figure 7) was comprised by i) three Vivaspin filters with 400 
uL of the nanogel – (BSA-FITC) solution, ii) the agarose gel phantom, iii) the 
water box connected to a water bath to keep the background temperature at 37 
°C, iv) a bow-tie dipole antenna for imaging and RF energy delivering, v) a 
customized high power transmit/receive (Tx/Rx) switch [1] to support high-power 
RF pulses and vi) fiber optic temperature sensors (Omniflex, Neoptix, Quebec, 
Canada) used as external temperature reference. 
 The phantom was placed in the water box and preheated overnight to 37 °C. In 
the next day, one vivaspin filter was placed in the middle sample holder of the 
hotspot area of the phantom, a second filter was placed in the control sample 
holder beyond the hotspot and a third filter was kept outside the MRI scanner 
room in the lab at room temperature (20 °C). All the sample holders were filled 
with 0.1 M NaCl solution (σ = 1.05 S/m, ε = 80.4) to avoid susceptibility artifacts. 
Four fiber optic temperature sensors were placed in the middle sample holder 
(heated sample), in the control sample holder, inside the phantom at depth of 15 
mm next to the middle sample holder, and inside the phantom at depth of 25 mm 
next to the middle sample holder. Then, the bow-tie dipole antenna would be 
placed on the lid of the water box, centered on the middle sample holder of the 
phantom. Next, the bow-tie dipole antenna would be tuned and matched to the 
B0 field frequency of the MR scanner (f = 297.2 MHz), then connected to the 






Figure 7 – a) Photograph of the RF heating setup for the MR scanner; the agarose gel 
phantom for holding the Vivaspin filter with the BSA-FITC loaded nanogels, the water 
box connected to a water bath for background temperature modification (in this case 37 
°C), a bow-tie dipole antenna for imaging and RF heating, a customized high-power 
Tx/Rx switch and fiber optic temperature sensors as temperature reference for MR 
thermometry. b) MR images of the phantom. The vivaspin tube with the nanogel sample 
in the middle sample holder (heated sample) is indicated by the yellow arrows. Left: axial 
view at a depth of 15 mm (at the level of the second row of the PTFE tubes). Right: axial 






2.2.6. Radiofrequency induced heating paradigm and protein release study 
The heating paradigm consisted of sending RF pulses with average power (Pavg) 
= 100 W at antenna feeding point for 15 minutes, interleaved every 5 minutes 
with 2D MR thermometry (MRTh) measurements.  
The RF power is provided by the 7.0 Tesla MR system amplifiers (8 kW peak 
power) with a rectangular pulse of 4 ms (U = 280 V) and TR of 40 ms, resulting 
in a duty cycle of 10%. The hardware losses between the transmitter and the 
feeding point of the bow-tie dipole antenna were 2.12 dB.  
MRTh was conducted using a proton resonance frequency shift method [26] and 
dual gradient-echo technique [27,28] (FOV = (290 × 290)  mm2, TR = 102ms, 
TE1 = 2.26 ms and TE2 = 11.44 ms, spatial resolution = (1.5 × 1.5 × 4) mm3, 
nominal flip angle = 30°). Fiber optic temperature sensors were used as external 
reference for the MRTh temperature maps. 
After reaching 43°C in the middle sample holder, the temperature was maintained 
with subsequent RF pulses for 1 to 2 minutes. At certain time intervals, Vivaspin 
filters were taken out, centrifuged (10 min, 4800 x g) and the filtrates were taken 
for analysis (fluorescence at λex/λem = 490/525 nm). Then, the fresh buffer was 
replaced and Vivaspin filters were placed again in the phantom. The filters were 







3.1. High-power Tx/Rx switch 
 
3.1.1. Tx/Rx switch performance 
The high-power Tx/Rx switch provided isolation of -29 dB between transmission 
port and receive port during the transmission mode and -39.1 dB during receive 
mode. The insertion loss was -0.3 dB between the Tx port and the antenna in the 
transmission mode and -0.3 dB between the antenna and the Rx port in the 
receive mode.  
After operating at an average power Pavg = 100 W for 30 min, the maximum 
temperature in the circuit of high-power Tx/Rx switch was 59.7 °C, in an inductor 
of receive compartment (Figure 8a,c). In comparison, the conventional imaging 
Tx/Rx switch circuit reached 97.5 °C in a pin diode after operating at 100 W for 2 
min (Figure 8b,d).  
 
Figure 8 – a) high power Tx/Rx switch and b) conventional Tx/Rx switch driving 100 W. 
c) Temperature in the circuit of high power switch after 30 min; background temperature 
(white +) = 24.9 °C, highest temperature (black +) = 59.7 °C. d) Temperature in 
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conventional switch after 2 min; background temperature (white +) = 23.7 °C, highest 
temperature (black +) = 97.5 °C. Image adapted from [1]. 
 
 
3.1.2. MR imaging test 
The high spatial resolution MR images (Figure 9) acquired with the high power 
Tx/Rx switch and a conventional Tx/Rx switch yielded similar image quality. On 
both images, one could appreciate many small structures such as carpal bones, 
ulnar disc, radio-carpal and ulnar-carpal joints and cartilage. The signal to noise 
ratio was 30.3 for high power Tx/Rx switch and 25.4 for conventional switch.  
 
 
Figure 9 – Wrist MRI performed with a) high power Tx/Rx switch and b) conventional 
switch. Image adapted from [1]. 
 
3.1.3. RF induced heating and MR thermometry 
In the RF heating experiments, the temperature increase in the phantom is 
greater when high power Tx/Rx switch was used; as higher power (100 W vs 25 
W) could be delivered. 
In the high power Tx/Rx switch setup, after 5, 10 and 15 min of RF heating with 
Pavg = 100 W, the temperature increase in the phantom at the depth of 15 mm 
(Figure 10a) was 5.9 ± 0.26, 13.6 ± 0.60 and 18.5 ± 0.40 °C, obtained from MRTh 
maps. The fiber optic probe positioned at the same location registered 6.7, 12.4 
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and 17.5 °C (Figure 10b). Temperature measured with MRTh and fiber optic 
probe had a deviation of 0.8-1.2 °C. 
In comparison, the temperature increase in the same location while using a 
conventional Tx/Rx switch with Pavg = 25 W (maximum Pavg allowed by 
manufacturer) was 2.3 ± 0.38, 4.3 ± 0.45 and 5.3 ± 0.37 °C obtained from MRTh 
maps and 1.7, 3.5 and 4.7 °C registered by the fiber optic probe (Figure 10b). 




Figure 10 – RF heating with high-power Tx/Rx switch, Pavg = 100 W vs conventional 
Tx/Rx switch, Pavg = 25 W. a) temperature maps calculated from MR thermometry 
(MRTh) using PRF method. b) temperature readings from MRTh maps and fiber optic 




3.2. Load release from thermoresponsive carriers  
 
3.2.1. Thermoresponsive nanogel characterization 
The synthesis of the Ac-dPG was confirmed by the chemical shifts in the 1H-NMR 
spectrum (Figure 11a): 3.1-4.5 ppm (multiplet, 5 H, polyglycerol protons), 5.98-
6.10 ppm (multiplet, 1 H, vinyl group), 6.15-6.30 ppm (multiplet, 1 H, vinyl group), 
6.40-6.53 ppm (multiplet, 1 H, viniyl group). 
By dynamic light scattering, the size of the nanogels was determined to be 105 
nm with a polydispersive index of 0.110. The structure of the nanogels was 
confirmed by the chemical shifts in the 1H-NMR spectrum (Figure 11b): 1.16 ppm 
(singlet, 6 H, isopropyl groups of PNIPAM and PNIPMAM), 1.57-2.17 ppm 
(multiplet, 3 H of polymer backbone of PNIPAM plus 2 H of polymer backbone of 
PNIPMAM), 3.37-4.10 ppm (multiplet, 7 H, polyglycerol scaffold protons plus 1 H 
of PNIPAM plus 1 H of PNIPMAM). 
The volume phase transition temperature (VPTT) defined as the temperature of 





Figure 11 – a) The synthesis of acrylated dendritic polyglycerol (Ac-dPG) was confirmed 
by the chemical shifts in the 1H-NMR spectrum: 3.1-4.5 ppm (multiplet, 5 H, polyglycerol 
protons), 5.98-6.10 ppm (multiplet, 1 H, vinyl group), 6.15-6.30 ppm (multiplet, 1 H, vinyl 
group), 6.40-6.53 ppm (multiplet, 1 H, viniyl group). D2O was used as solvent (4.8 ppm). 
b) The structure of the nanogels was confirmed by the chemical shifts in the 1H-NMR 
spectrum: 1.16 ppm (singlet, 6 H, isopropyl groups of PNIPAM and PNIPMAM), 1.57-
2.17 ppm (multiplet, 3 H of polymer backbone of PNIPAM plus 2 H of polymer backbone 
of PNIPMAM), 3.37-4.10 ppm (multiplet, 7 H, polyglycerol scaffold protons plus 1 H of 
PNIPAM plus 1 H of PNIPMAM). D2O was used as solvent (4.8 ppm). c) Nanogel size 
vs temperature curve. The volume phase transition temperature (VPTT) defined as the 
temperature of the inflection point of this curve is found to be 38 °C. Data collected by 
Dr. Lucila Navarro, Freie Universität Berlin. 
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3.2.2. Protein release from nanogel: in water bath  
 
The release of BSA-FITC from the nanogels using water bath as a heat source 
is shown in the graph of Figure 12. 
At room temperature of 20 °C (18 °C lower than VPTT = 38 °C), the release of 
the BSA-FITC from the nanogels was 12.5% after 6 hours and 14.1% after 19 
hours. 
At 37 °C (1 °C less than VPTT), the release of the BSA-FITC from the nanogels 
was 19.5% after 6 hours and 27.6% after 19 hours. 
At 43 °C (5 °C higher than the VPTT) the release of the BSA-FITC from the 




Figure 12 – Bovine saline albumin labelled with fluorescein (BSA-FITC) release from the 
nanogels using water bath as heat source. After 6 hours, 12.5%, 19.5% and 32.8% of 
the BSA-FITC were released from the nanogels at 20 °C, 37 °C and 43 °C, respectively. 
After 19 hours, 14.1%, 27.6% and 43.6% of the BSA-FITC were released from the 





3.2.3. Temperature simulations of the phantom 
The temperature maps (Figure 13) obtained from the electromagnetic and thermal 
simulations of the phantom using a background temperature of 37 °C yielded T = 
43 °C (t = 11 min, Pavg = 100 W) for the middle sample holder. The temperature 
obtained for the controlled sample holder remained constant at T=37 °C.  
 
 
Figure 13 – Simulated radiofrequency induced heating in the phantom with Pavg = 100 
W for 15 minutes. a) Simulated temperature distribution in the phantom (depth = 25 mm, 
coronal plane) at 5, 10 and 15 minutes. b) Time dependent temperature evolution in the 
heated sample (red cross) compared to the control sample (blue cross). The schematic 
of the phantom on the right hand side shows the coronal plan where the temperature 
distribution maps were taken. The data shows that the RF heating is constrained to the 





3.2.4. RF heating of the phantom 
The temperature changes in the phantom during RF heating were accessed with 
readings from fiber optic temperature sensors and MR thermometry (MRTh) and 
it is shown in Figure 14. 
The fiber optic temperature sensor readings from the controlled sample holder 
maintained consistently at 37 °C. In the heated sample, the reading was 38.8 °C 
after the first 5 minutes of RF heating, 40.9 °C after the second 5 minutes RF 
heating and 43.4 after the third 5 minutes of RF heating. 
The reading from the fiber optic temperature sensor inside the phantom at 25 mm 
was 38.8 °C after the first 5 min RF heating session, while the temperature map 
obtained with MR thermometry at that moment showed 38.6 °C. After the second 
5 min RF heating, the fiber optic temperature sensor registered 40.47 °C, and the 
MRTh 40.0 °C. Finally, after the last 5 minutes of RF heating, the fiber optic 
temperature sensor marked 42.5 °C, and the MRTh 41.7 °C.  
 
3.2.5. Protein release from nanogel: Thermal MR  
 
The release of BSA-FITC from the nanogels using RF energy as heat source 
(thermal MR) is shown in graph of the Figure 15. 
At room temperature of 20 °C (18 °C lower than VPTT = 38 °C), the release of 
the BSA-FITC from the nanogels was 12.9% after 6 hours. 
At 37 °C (1 °C less than VPTT), the release of the BSA-FITC from the nanogels 
was 19.6% after 6 hours. 
At 43 °C (5 °C higher than the VPTT), the release of the BSA-FITC from the 






Figure 14 – a) Temperature distribution maps in the phantom at depth = 25 mm obtained 
with MR thermometry. To guide the eye, the grey circles were inserted to mark the 
sample holders and the black rectangle marked the position of the fiber optic temperature 
sensor. b) The temperature along time from the fiber optic temperature sensor readings 
in the controlled sample holder (blue), in the heated sample holder (red) and inside 
phantom next to the heated sample (black rectangle in a), and temperature obtained by 






Figure 15 – Bovine serum albumin labelled with fluorescein (BSA-FITC) released from 
the nanogels using RF heating from thermal MR. After 6 hours, 12.9%, 19.6% and 29.3% 





4. Discussion and Conclusion 
 
In the first part of this work, the constructed high power Tx/Rx switch for thermal 
MR applications provided high isolation and low insertion loss. When 
benchmarked against a conventional Tx/Rx switch, it proved to be capable of 
handling a high average power, necessary for RF heating (100 W) without 
causing overheating in the circuit. This shows that the design of high power Tx/Rx 
switch was effectively blocking the RF waves from the lossy pin diodes preventing 
energy loss that was translated into increased temperature in the conventional 
Tx/Rx switch. Overheating in the circuit is unsafe as it can burn up electronic 
components or cause melting of solder inducing open or short circuits that 
compromise the overall performance of the circuit.  
When tested for MR imaging, the high power Tx/Rx switch supported high 
resolution imaging of the wrist. The many small and clinically relevant structures 
such as carpal bones, discs, joints, and cartilage are well depicted in the images. 
Compared to a conventional Tx/Rx switch, the high power Tx/Rx switch displayed 
similar image quality.  
The RF heating experiments showed the limitation of conventional switch and 
thus the need for an alternative circuit design that could handle higher power 
demands. The high power switch design could support RF heating with average 
power of 100 W. Although only one bow tie antenna was used, after 5 min it could 
induce ~6 °C of temperature increase at the depth of 15 mm of the phantom. In 
a biological system, an increase of 6 °C will put it under hyperthermia conditions.  
Upon the positive results obtained by hardware development, in the second part 
of this work, the thermal intervention potential of the setup was exploited to 
demonstrate the feasibility of the temperature induced release of a protein from 
a thermoresponsive nanogel in a 7.0 T MR system.  
The reference release profile obtained with a water bath setup used for 
temperature intervention is in accordance with the release kinetics deduced from 
the thermal MR setup.  This finding supports the feasibility of thermal MR for 




In this study, a single bow-tie dipole antenna has been used for imaging, 
temperature intervention, and temperature monitoring. This approach 
constrained the heating rate to T = 0.3 °C per minute for a peak power of P = 
100 W and a duty cycle of 10%. To enhance the heating rate, an array of RF 
antenna can be exploited [6,29]. This approach would afford shaping and steering 
of the temperature hotspot and would support parallel MR imaging to reduce 
acquisition times needed for temperature monitoring of larger volumes [30,31]. 
In this work, a fluorescence labelled protein was loaded to thermoresponsive 
nanogels and the release characteristics were studied with fluorescence 
spectroscopy upon conventional water bath heating or after Thermal MR 
intervention. Swift translation of Thermal MR triggered release of a load from a 
nanocarrier remains conceptually appealing and an ambitious undertaking en 
route to clinical feasibility studies of thermal therapeutics. For the assessment of 
the efficacy of thermal interventions, it is of paramount importance to examine the 
release rate and kinetics in vivo. Here, thermoresponsive nanocarriers loaded 
with MR sensitive fluorine probes could provide ideal means to monitor release 
kinetics and bioavailability [32] of the MR visible load in vivo, which would be a 
major leap forward to temperature induced drug delivery. While the current work 
used a thermoresponsive nanogel as a carrier, the Thermal MR triggered release 
of payloads from other thermoresponsive carriers is to be expected to be also 
feasible. Further smart carriers that, in addition to temperature, also respond to 
internal variation in the microenviroment of certain diseases [14,19] (pH 
variations, hormone concentrations, redox gradient, etc.) are also interesting 
study candidates.  
MRI is a vital clinical tool for diagnosis and for guiding therapy. MRI has been 
described as one of the most important medical innovations [33,34]. Current 
clinical MR approaches offer no integrated means for diagnosis and thermal 
intervention (thermo-theranostics), inherent to the RF fields applied. 
Simultaneously accommodating thermal diagnostics, intervention and response 
control is conceptually intriguing for the pursuit personalized therapeutic 
approaches for better patient care and for the study of the role of temperature in 
biology and disease. In conclusion, the Thermal MR approach adds a thermal 
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intervention dimension to an MR imaging device and provides an ideal testbed 
for the study of temperature induced release of drugs, MR probes and other 
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